Danger associated molecular patterns in injury: a double-edged sword?
1 Immunology Department, Hospices Civils de Lyon, Lyon University Hospital, Edouard Herriot Hospital, Lyon, France ; 2 Université de Lyon, Claude Bernard University, EA PI3 "Pathology of Injury-induced Immunosuppression", Lyon, France ; 3 Department of Medical Intensive Care Unit, Hospices Civils de Lyon, Lyon University Hospital, Edouard Herriot Hospital, Lyon, France ; 4 INSERM UMR 1060, CarMeN, Team 5 "Cardioprotection", Lyon, France.
Guillaume
G
Monneret
1 Immunology Department, Hospices Civils de Lyon, Lyon University Hospital, Edouard Herriot Hospital, Lyon, France ; 2 Université de Lyon, Claude Bernard University, EA PI3 "Pathology of Injury-induced Immunosuppression", Lyon, France ; 3 Department of Medical Intensive Care Unit, Hospices Civils de Lyon, Lyon University Hospital, Edouard Herriot Hospital, Lyon, France ; 4 INSERM UMR 1060, CarMeN, Team 5 "Cardioprotection", Lyon, France.
Fabienne
F
Venet
1 Immunology Department, Hospices Civils de Lyon, Lyon University Hospital, Edouard Herriot Hospital, Lyon, France ; 2 Université de Lyon, Claude Bernard University, EA PI3 "Pathology of Injury-induced Immunosuppression", Lyon, France ; 3 Department of Medical Intensive Care Unit, Hospices Civils de Lyon, Lyon University Hospital, Edouard Herriot Hospital, Lyon, France ; 4 INSERM UMR 1060, CarMeN, Team 5 "Cardioprotection", Lyon, France.
Martin
M
Cour
1 Immunology Department, Hospices Civils de Lyon, Lyon University Hospital, Edouard Herriot Hospital, Lyon, France ; 2 Université de Lyon, Claude Bernard University, EA PI3 "Pathology of Injury-induced Immunosuppression", Lyon, France ; 3 Department of Medical Intensive Care Unit, Hospices Civils de Lyon, Lyon University Hospital, Edouard Herriot Hospital, Lyon, France ; 4 INSERM UMR 1060, CarMeN, Team 5 "Cardioprotection", Lyon, France.
Laurent
L
Argaud